BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 16226064)

  • 1. From chance to frequent encounters: origins of beta2-microglobulin fibrillogenesis.
    Eakin CM; Miranker AD
    Biochim Biophys Acta; 2005 Nov; 1753(1):92-9. PubMed ID: 16226064
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Formation of a stable oligomer of beta-2 microglobulin requires only transient encounter with Cu(II).
    Calabrese MF; Miranker AD
    J Mol Biol; 2007 Mar; 367(1):1-7. PubMed ID: 17254602
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Kidney dialysis-associated amyloidosis: a molecular role for copper in fiber formation.
    Morgan CJ; Gelfand M; Atreya C; Miranker AD
    J Mol Biol; 2001 Jun; 309(2):339-45. PubMed ID: 11371157
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glycosaminoglycans enhance the fibrillation propensity of the β2-microglobulin cleavage variant--ΔK58-β2m.
    Corlin DB; Johnsen CK; Nissen MH; Heegaard NH
    Biochem Biophys Res Commun; 2010 Nov; 402(2):247-51. PubMed ID: 20939999
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A native to amyloidogenic transition regulated by a backbone trigger.
    Eakin CM; Berman AJ; Miranker AD
    Nat Struct Mol Biol; 2006 Mar; 13(3):202-8. PubMed ID: 16491088
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metal binding sheds light on mechanisms of amyloid assembly.
    Calabrese MF; Miranker AD
    Prion; 2009; 3(1):1-4. PubMed ID: 19377278
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oligomeric assembly of native-like precursors precedes amyloid formation by beta-2 microglobulin.
    Eakin CM; Attenello FJ; Morgan CJ; Miranker AD
    Biochemistry; 2004 Jun; 43(24):7808-15. PubMed ID: 15196023
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mechanism of lysophosphatidic acid-induced amyloid fibril formation of beta(2)-microglobulin in vitro under physiological conditions.
    Pál-Gábor H; Gombos L; Micsonai A; Kovács E; Petrik E; Kovács J; Gráf L; Fidy J; Naiki H; Goto Y; Liliom K; Kardos J
    Biochemistry; 2009 Jun; 48(24):5689-99. PubMed ID: 19432419
    [TBL] [Abstract][Full Text] [Related]  

  • 9. beta(2)-microglobulin: from physiology to amyloidosis.
    Heegaard NH
    Amyloid; 2009; 16(3):151-73. PubMed ID: 19657763
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ultrastructural localization of advanced glycation end products and beta2-microglobulin in dialysis amyloidosis.
    Brancaccio D; Gallieni M; Niwa T; Braidotti P; Coggi G
    J Nephrol; 2000; 13(2):129-36. PubMed ID: 10858976
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A beta2-microglobulin cleavage variant fibrillates at near-physiological pH.
    Corlin DB; Johnsen CK; Nissen MH; Heegaard NH
    Biochem Biophys Res Commun; 2009 Apr; 381(2):187-91. PubMed ID: 19232323
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Using mass spectrometry to study copper-protein binding under native and non-native conditions: beta-2-microglobulin.
    Lim J; Vachet RW
    Anal Chem; 2004 Jul; 76(13):3498-504. PubMed ID: 15228316
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular interactions in the formation and deposition of beta2-microglobulin-related amyloid fibrils.
    Naiki H; Yamamoto S; Hasegawa K; Yamaguchi I; Goto Y; Gejyo F
    Amyloid; 2005 Mar; 12(1):15-25. PubMed ID: 16076607
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Specific glycosaminoglycans promote unseeded amyloid formation from beta2-microglobulin under physiological conditions.
    Borysik AJ; Morten IJ; Radford SE; Hewitt EW
    Kidney Int; 2007 Jul; 72(2):174-81. PubMed ID: 17495865
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of β2-microglobulin conformational intermediates associated to different fibrillation conditions.
    Santambrogio C; Ricagno S; Sobott F; Colombo M; Bolognesi M; Grandori R
    J Mass Spectrom; 2011 Aug; 46(8):734-41. PubMed ID: 21766392
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Circulating level of alpha2-macroglobulin-beta2-microglobulin complex in hemodialysis patients.
    Motomiya Y; Ando Y; Haraoka K; Sun X; Iwamoto H; Uchimura T; Maruyama I
    Kidney Int; 2003 Dec; 64(6):2244-52. PubMed ID: 14633149
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increase in the conformational flexibility of beta 2-microglobulin upon copper binding: a possible role for copper in dialysis-related amyloidosis.
    Villanueva J; Hoshino M; Katou H; Kardos J; Hasegawa K; Naiki H; Goto Y
    Protein Sci; 2004 Mar; 13(3):797-809. PubMed ID: 14767076
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Small molecule-mediated inhibition of β-2-microglobulin-based amyloid fibril formation.
    Marcinko TM; Dong J; LeBlanc R; Daborowski KV; Vachet RW
    J Biol Chem; 2017 Jun; 292(25):10630-10638. PubMed ID: 28468825
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A recurrent D-strand association interface is observed in β-2 microglobulin oligomers.
    Colombo M; de Rosa M; Bellotti V; Ricagno S; Bolognesi M
    FEBS J; 2012 Mar; 279(6):1131-43. PubMed ID: 22289140
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular basis for the Cu2+ binding-induced destabilization of beta2-microglobulin revealed by molecular dynamics simulation.
    Deng NJ; Yan L; Singh D; Cieplak P
    Biophys J; 2006 Jun; 90(11):3865-79. PubMed ID: 16513784
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.